Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer’s Treatment
Investor's Business DailyBiogen stock jumped Wednesday after the FDA gave its Eisai-partnered Alzheimer’s treatment a fast track designation.
The post Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer's Treatment appeared first on Investor's Business Daily.